Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Neth Heart J. 2009 Nov;17(11):409-13. doi: 10.1007/BF03086293.
Background and Objective. The Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS) has shown that thrombus aspiration improves myocardial perfusion and clinical outcome compared with conventional primary percutaneous coronary intervention (PCI) in patients with ST-segment-elevation myocardial infarction. Impaired myocardial perfusion due to spontaneous or angioplasty-induced embolisation of atherothrombotic material also occurs in patients with non-ST-elevation myocardial infarction (NSTEMI). The aim of this study is to determine whether thrombus aspiration before stent implantation will result in improved myocardial perfusion in patients with NSTEMI compared with conventional PCI.Study design. The study is a single-centre, prospective, randomised trial with blinded evaluation of endpoints. The planned inclusion is 540 patients with acute NSTEMI who are candidates for urgent PCI. Patients are randomised to treatment with manual thrombus aspiration or to conventional PCI. The primary endpoint is the incidence of myocardial blush grade 3 after PCI. Secondary endpoints are coronary angiographic, histopathological, enzymatic, electrocardiographic and clinical outcomes including major adverse events at 30 days and one year.Implications. If thrombus aspiration leads to significant improvement of myocardial perfusion in patients with acute NSTEMI it may become part of the standard interventional approach. (Neth Heart J 2009;17:409-13.).
背景和目的。经皮冠状动脉介入治疗急性心肌梗死血栓抽吸研究(TAPAS)表明,与常规直接经皮冠状动脉介入治疗(PCI)相比,急性 ST 段抬高型心肌梗死患者血栓抽吸可改善心肌灌注和临床预后。非 ST 段抬高型心肌梗死(NSTEMI)患者也会因动脉粥样硬化血栓物质自发或血管成形术后栓塞导致心肌灌注受损。本研究旨在确定与常规 PCI 相比,在支架植入前进行血栓抽吸是否会改善 NSTEMI 患者的心肌灌注。
研究设计。该研究是一项单中心、前瞻性、随机临床试验,终点评估为盲法。计划纳入 540 例急性 NSTEMI 患者,这些患者为紧急 PCI 的候选者。患者随机分为接受手动血栓抽吸治疗或常规 PCI 治疗。主要终点是 PCI 后心肌灌注分级 3 的发生率。次要终点是冠状动脉造影、组织病理学、酶学、心电图和临床结局,包括 30 天和 1 年时的主要不良事件。
意义。如果血栓抽吸可显著改善急性 NSTEMI 患者的心肌灌注,则可能成为标准介入治疗方法的一部分。(荷兰心脏杂志 2009;17:409-13.)。